112 related articles for article (PubMed ID: 27245016)
1. [Analysis of influencing factors on adverse reaction of Shengfu injection based on prospective active safety monitoring].
Wang ZF; Zhao W; Zhang Y; Xie YM
Zhongguo Zhong Yao Za Zhi; 2015 Dec; 40(24):4746-51. PubMed ID: 27245016
[TBL] [Abstract][Full Text] [Related]
2. [Clinical safety imtensive hospital monitoring on Shenfu injection with 30 106 cases].
Wang ZF; Yu JY; Xie YM
Zhongguo Zhong Yao Za Zhi; 2017 Aug; 42(15):2871-2876. PubMed ID: 29139250
[TBL] [Abstract][Full Text] [Related]
3. [Clinical safety studies based on 30 026 post-marketing cases of Shenqi Fuzheng injection by intensive hospital monitoring nested NCCS].
Wang LX; Xie YM; Ai QH; Xu WF
Zhongguo Zhong Yao Za Zhi; 2015 Dec; 40(24):4739-45. PubMed ID: 27245015
[TBL] [Abstract][Full Text] [Related]
4. [Influencing factor and mechanism analysis of adverse drug reaction in traditional Chinese medicine injection].
Wei X; Xie YM
Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2748-51. PubMed ID: 23285926
[TBL] [Abstract][Full Text] [Related]
5. [Adverse drug reactions induced by Mailuoning injection: literature review on 162 cases].
Xing GY; Li CY; Yang YX
Zhongguo Zhong Yao Za Zhi; 2008 Jun; 33(11):1322-6. PubMed ID: 18831218
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of 103 cases with adverse drug reactions induced by sanqizongzaogan injection].
Chen Y; Li Y; Zhu G
Zhongguo Zhong Yao Za Zhi; 2010 Jan; 35(2):237-9. PubMed ID: 20394303
[TBL] [Abstract][Full Text] [Related]
7. [Apply association rules to analysis adverse drug reactions of shuxuening injection based on spontaneous reporting system data].
Yang W; Xie YM; Xiang YY
Zhongguo Zhong Yao Za Zhi; 2014 Sep; 39(18):3616-20. PubMed ID: 25532406
[TBL] [Abstract][Full Text] [Related]
8. Adverse drug reactions of Shenmai injection: a systematic review.
Zhang L; Hu J; Xiao L; Zhang Y; Zhao W; Zheng W; Shang H
J Evid Based Med; 2010 Aug; 3(3):177-82. PubMed ID: 21349063
[TBL] [Abstract][Full Text] [Related]
9. [Nested case control study to analyze suspected cases and their related factors of allargic reactions to parenterally administered dengzhan xixin].
Yang W; Cheng H; Xie YM; Yang H; Zhuang Y
Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):3024-7. PubMed ID: 24471324
[TBL] [Abstract][Full Text] [Related]
10. [32 546 intensive hospital monitoring cases of Shuxuetong injection].
Jiang JJ; Xie YM; Zhang Y; Yang ZX; Yi DH
Zhongguo Zhong Yao Za Zhi; 2016 Oct; 41(20):3852-3858. PubMed ID: 28929666
[TBL] [Abstract][Full Text] [Related]
11. [Preliminary study on general safe medication regularity of Chinese patent orthopedic medicines based on adverse reaction/event literature analysis].
Wang YG; Shi XY; Jin R; Li HY; Kong XW; Qiao YJ
Zhongguo Zhong Yao Za Zhi; 2015 Mar; 40(6):1192-7. PubMed ID: 26226769
[TBL] [Abstract][Full Text] [Related]
12. [Study of post marketing safety reevaluation of shenqi fuzheng injection].
Ai QH; Li YY; Xie YM
Zhongguo Zhong Yao Za Zhi; 2014 Sep; 39(18):3633-6. PubMed ID: 25532410
[TBL] [Abstract][Full Text] [Related]
13. [Post-marketing clinical safety assessment of Shenmai injection based on active monitoring and passive monitoring in large data background].
Wang LX; Xie YM; Ai QH; Song NB
Zhongguo Zhong Yao Za Zhi; 2015 Dec; 40(24):4752-6. PubMed ID: 27245017
[TBL] [Abstract][Full Text] [Related]
14. [A postmarketing surveillance study on 31,724 patients using Dengzhan Xixin injection in hospital].
Li YY; Lei L; Xie YM
Zhongguo Zhong Yao Za Zhi; 2015 Dec; 40(24):4757-61. PubMed ID: 27245018
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of adverse reactions and pharmacovigilance research to parenterally administered shuxuening].
Yang W; Xiang YY; Xie YM; Shen H
Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):3013-8. PubMed ID: 24471322
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of questionable allergic factors to kudiezi injection--nested case control study using hospital information system data].
Liao X; Zeng XB; Xie YM; Yang W; Ai QH
Zhongguo Zhong Yao Za Zhi; 2014 Sep; 39(18):3559-62. PubMed ID: 25532395
[TBL] [Abstract][Full Text] [Related]
17. [Security revaluation study based on nested case-control method of Danhong injection].
Li CX; Tang JF; Meng F; Li XL
Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2735-8. PubMed ID: 23285922
[TBL] [Abstract][Full Text] [Related]
18. [Adverse drug reactions case reports for parenterally administered shuxuening based on analysis of literature].
Ai QH; Wei X; Xie YM; Liao X; Wang ZF
Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):3190-4. PubMed ID: 24471350
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation on safety of puerarin injection in clinical use].
Xie XS; Dong YZ; Mu DP; Pan XL; Zhang FY
Zhongguo Zhong Yao Za Zhi; 2018 Oct; 43(19):3956-3961. PubMed ID: 30453723
[TBL] [Abstract][Full Text] [Related]
20. [Protocol of intensive hospital monitoring with long follow up and large sample: Diemailing Kudiezi injection as example].
Liao X; Xie YM; Wang GQ
Zhongguo Zhong Yao Za Zhi; 2016 Dec; 41(24):4494-4499. PubMed ID: 28936829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
